Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ProMedicus.
RELATED STOCKHEAD STORIES
News
Closing Bell: ASX holds steady on good day for miners… and Chemist Warehouse
Health & Biotech
Health Check: Despite a ‘biggest ever’ December half, Pro Medicus says it’s just revving up in the US
Experts
Criterion: Where to unearth value in the profit-reporting period
Health & Biotech
Scott Power: ASX health stocks drop as Trump’s proposed tariffs rattle global markets
News
Lunch Wrap: Trump’s tariff delay sparks ASX bounce; Seek’s deal with Xref collapses
Health & Biotech
Health Check: Good golly Miss Molly! Emyria says Ecstasy works for PTSD, months after treatment
Health & Biotech
Scott Power: Telix achieves sustained growth; Pro Medicus wins another contract
Health & Biotech
Health Check: Pro Medicus lands $33m deal; RoXsta antioxidant profiling shows potential
News
Skin in the game: Why investing in founder-led companies can pay off
Experts
Experts break down all 11 ASX sectors and serve up some stock tips
Health & Biotech
Biocurious: With its pre-budget ‘wish list’, Ausbiotech prepares to bat for the sector in Canberra
Experts
Criterion: Where to dig for share value in 2025 (and we’re not talking mining)
Health & Biotech
Health Check: Local biotech starred in 2024, but the rising tide did not lift all boats
Health & Biotech
Health Check: With yet another customer win, Pro Medicus storms to 2024 finish line with a wet sail
Health & Biotech
ASX healthcare 2024 winners and losers, plus what’s next for 2025
Health & Biotech
Health Check: Biotech’s forgotten tortoises pick up the pace as sector emerges from two-year slump
News